Standardized ratings from 0 through 6 describe breast-imaging findings and specify the evaluation they require. They range from an incomplete examination to cancer confirmed by biopsy, but no rating alone constitutes a complete cancer diagnosis or treatment plan.
This guide explains mammography, breast ultrasound, and breast MRI assessments, helping you read a report, understand follow-up, and prepare questions for your care team.
How the Breast Imaging Reporting and Data System Works
Shared terminology gives clinicians a consistent way to describe an abnormality and recommend its next evaluation. The American College of Radiology developed BI-RADS so mammography, ultrasound, and MRI reports can communicate findings across clinical settings.
The full name is Breast Imaging Reporting and Data System. Its assessment categories apply to breast imaging, but a finding still depends on the images, the examined area, the imaging method, and the clinical reason for the examination.
What each assessment communicates
An assessment has two connected parts: the radiologist’s description of the finding and the management that fits the available evidence. Standard wording helps the ordering clinician understand whether the result is negative, benign, probably benign, suspicious, or biopsy-confirmed.
A small focus on a mammogram, for example, may lead to a preliminary category 4 while targeted ultrasound is pending. Additional images can change the assessment if they show a simple cyst rather than a persistent solid abnormality.
Because additional images can alter the preliminary assessment, the radiologist’s degree of suspicion determines the final category.
The category describes an imaging finding and its recommended management. It does not establish tumor type, disease stage, or an individual treatment plan without pathology and clinical evaluation.
| Report component | What it communicates | What it does not establish |
|---|---|---|
| BI-RADS assessment | Imaging features, concern level, and the evaluation pathway | A complete cancer diagnosis or care plan |
| Imaging findings | What appeared on the examined images | The biological cause of every visible feature |
| Pathology result | What microscopic analysis of sampled tissue found | The stage or full extent of an individual cancer |
How Suspicion Determines the Assessment Level
Suspicion rises as an examination moves from incomplete imaging to a biopsy-confirmed malignancy. That structure makes the 0-to-6 sequence different from a simple yes-or-no cancer test.
A radiologist evaluates shape, margins, density, internal appearance, and growth compared with earlier studies. Mammography and ultrasound may display the same area differently, so the assessment reflects all relevant evidence from the examination.
The recommendation depends on more than the visible shape alone. Personal and family history, symptoms, breast density, prior imaging, and the reason for the study can affect how an otherwise similar finding is managed.
Why category 4 has three subdivisions
Category 4 covers an estimated malignancy risk above 2% but below 95%, which is too broad for one management decision. Subcategories 4A, 4B, and 4C divide that range into lower, intermediate, and high levels of concern.
A preliminary 4A assessment may be assigned while targeted ultrasound remains pending. If the added examination demonstrates a simple cyst, the radiologist may lower the final assessment to category 2 rather than carry an unnecessary suspicion into follow-up.
| Category | Estimated malignancy risk | Core interpretation | Usual next direction |
|---|---|---|---|
| 0 | Not assigned | Incomplete examination | Obtain additional imaging |
| 1 | Essentially no concern | Negative | Routine screening or an established clinical plan |
| 2 | Essentially no concern | Benign | Routine screening or an established clinical plan |
| 3 | No greater than 2% | Probably benign | Short-interval follow-up in many cases |
| 4 | More than 2% and less than 95% | Suspicious | Further evaluation, which may include biopsy |
| 4A | More than 2% and no greater than 10% | Lower suspicion | Management selected for the finding and clinical context |
| 4B | More than 10% and less than 50% | Intermediate suspicion | Management selected for the finding and clinical context |
| 4C | 50% to less than 95% | High suspicion within category 4 | Management selected for the finding and clinical context |
| 5 | At least 95% | Strongly suggestive of malignancy | Tissue sampling is normally recommended |
| 6 | Not used for risk estimation | Known biopsy-proven malignancy | Specialist evaluation and treatment planning |
What Categories 0 Through 2 Mean
Three possible outcomes address an inadequate examination, the absence of suspicious findings, or a documented benign feature. A simple cyst on targeted ultrasound, for example, can support a reassuring category 2 assessment.
Why category 0 remains incomplete
Category 0 means the available images do not support a reliable final assessment. Overlapping tissue, a skin fold, or a dense area may obscure an apparent density or limit evaluation of a specific area.
The radiologist may request additional mammographic views, breast ultrasound, or a later examination. A new angle can reveal that an apparent density was caused by superimposed tissue rather than a discrete lesion.
You should confirm which examination is needed, when it will occur, and who will communicate the final result. A portal entry of 0 is not a cancer assessment; it is a request to complete the imaging process.
How categories 1 and 2 differ
Category 1 records a negative examination with no suspicious abnormality on the reviewed images. Category 2 records a benign feature, such as a simple cyst or a clearly benign calcification pattern.
Both ratings are reassuring, but they communicate different observations. Category 1 describes an examination without a suspicious finding, while category 2 explains that something visible was assessed as benign.
Imaging does not answer every clinical question. A new lump, skin change, or nipple discharge still requires medical evaluation even when the mammogram or ultrasound receives category 1 or 2.
| Category | What the radiologist found | What it does not mean |
|---|---|---|
| 0 | Not enough imaging for a final assessment | Cancer is present or absent |
| 1 | No suspicious abnormality is identified | Symptoms or disease outside the images can be excluded |
| 2 | A benign finding is present | Every unrelated breast symptom has been evaluated |
What Categories 3 Through 6 Mean
Four escalating levels distinguish degrees of uncertainty or concern on the breast-imaging assessment scale. A probably benign finding may need follow-up, suspicious findings need further evaluation, and category 6 applies only after biopsy has confirmed cancer.
Why category 3 preserves some uncertainty
Category 3 is probably benign and carries an estimated malignancy risk of no greater than 2%. It does not mean cancer is present, but the finding may require short-interval imaging to confirm stability.
That follow-up interval depends on the imaging method, the specific feature, breast density, symptoms, and available comparison studies. Some findings considered probably benign on one examination are managed differently on MRI or in a higher-risk clinical setting.
A new lump or other symptom can change the pathway even when the radiologist describes an imaging feature as probably benign. Clinical symptoms and imaging are assessed together rather than as substitutes.
How categories 4 and 5 guide testing
Category 4 indicates enough concern to justify additional evaluation, and biopsy may be part of that pathway. Category 5 indicates an estimated malignancy risk of at least 95%, so tissue sampling is normally recommended to establish the diagnosis.
The number does not tell you which test must occur next. A radiologist may use additional mammographic views, targeted ultrasound, or MRI when those examinations can resolve a specific uncertainty.
If the appearance remains suspicious, the evaluation may proceed to image-guided biopsy. A negative ultrasound result does not automatically settle the question if other mammographic or clinical features remain concerning.
What changes after biopsy confirms malignancy
Category 6 means pathology has already established the presence of cancer, so it is no longer a risk estimate. The rating does not determine tumor type, stage, lymph-node status, or the full treatment pathway.
Those decisions require pathology details, examination of the breast and nearby lymph nodes, and other clinical assessments. A breast specialist then combines the results with the patient’s preferences and overall health into an individualized plan.
| Assessment | What it means | What commonly follows |
|---|---|---|
| 3 | Probably benign, with no greater than 2% estimated risk | Short-interval imaging or a finding-specific alternative pathway |
| 4 | More than 2% and less than 95% estimated risk | Additional imaging, biopsy, or both according to the finding |
| 4A | More than 2% and no greater than 10% estimated risk | Management matched to the lower level of suspicion |
| 4B | More than 10% and less than 50% estimated risk | Further evaluation with an emphasis on tissue diagnosis when appropriate |
| 4C | 50% to less than 95% estimated risk | Further evaluation that commonly includes biopsy |
| 5 | At least 95% estimated risk | Tissue sampling is normally recommended |
| 6 | Biopsy has confirmed cancer | Oncology and breast-care planning |
How Clinical Details Change the Follow-Up
Because a management category must fit the person as well as the image, symptoms and history can alter follow-up. A round mass that remains unchanged across several studies receives a different interpretation from a new irregular mass in the same location.
What clinicians consider beyond the image
Radiologists combine visible features with symptoms, breast density, examination purpose, and prior studies. Personal and family history may also influence the choice of mammography, ultrasound, MRI, biopsy, or surveillance.
- Current symptoms: A new lump, skin change, or nipple symptom can require evaluation beyond the mammographic appearance.
- Breast density: Dense tissue can conceal or complicate some findings, affecting image interpretation and supplemental testing.
- Prior examinations: Earlier images may establish that an area is new, unchanged, or growing over time.
- Imaging modality: Mammography, ultrasound, and breast MRI display tissue differently and answer different imaging questions.
- Feature characteristics: Shape, margins, internal appearance, and growth pattern affect the estimated malignancy risk.
- Clinical history: Previous findings, relevant family history, and the reason for imaging add context to the visible feature.
Stability is useful evidence, not an automatic guarantee. A radiologist still evaluates whether the finding’s imaging characteristics support surveillance or require tissue sampling.
How additional examinations narrow uncertainty
Additional mammographic views can separate overlapping tissue from a persistent lesion. Targeted ultrasound may show fluid, a solid structure, or no corresponding abnormality, while MRI can map an area or provide more information in selected situations.
Breast MRI is not automatically required for every suspicious mammogram. The appropriate examination depends on the finding, clinical context, prior imaging, and whether the result will change management.
None of these modalities replaces pathology when tissue sampling is needed. Each answers a different question, so the radiologist combines all relevant results before choosing the evaluation pathway.
Those combined results appear in the report, where the assessment and recommended next steps are recorded in radiologist language.
How to Read Your Imaging Report
Because a category is only one part of the report, locate the final assessment, the described finding, and the named recommendation. A category 3 entry remains incomplete as a care plan until you know the follow-up interval and who will coordinate it.
Six steps for reviewing the result
- Locate the assessment: Find the final category stated after your mammogram, breast ultrasound, or breast MRI.
- Read the finding: Note the location, size when provided, shape, and the reason the radiologist assigned that level of concern.
- Check completeness: Category 0 requires more imaging before a reliable final assessment can be made.
- Record the recommendation: Look for a named follow-up interval, referral, additional examination, biopsy, or routine-screening plan.
- Compare prior studies: Ask whether the area is new, stable, or changed and how that comparison affected the assessment.
- Confirm coordination: Establish which clinician will review the results, explain them, and arrange any recommended evaluation.
A report may also identify the breast and precise location using clock-face position or distance from the nipple. Those details help clinicians match the finding across mammography, ultrasound, MRI, and subsequent examinations.
Prepare specific questions rather than focusing only on the number. Ask what finding received the assessment, what evidence supports it, whether comparison images were available, and what must happen to complete the evaluation.
Bring the complete report and earlier images to an appropriate specialist, especially when the recommended examination has not been arranged. A portal entry may omit context that appears in the final radiology report.
When Incomplete Information or Symptoms Require Prompt Contact
Contact a healthcare professional promptly for a new lump, skin change, nipple symptom, or unexplained discharge, regardless of a reassuring imaging category. A result may also be unresolved if imaging was incomplete, communication failed, or a recommended test did not occur.
Do not assume that a negative or benign rating rules out every form of breast cancer. The examination applies to the tissue and findings visualized during that study, and a new symptom requires a new clinical evaluation.
Ask the ordering clinician or breast specialist to confirm the next appointment, document the recommended interval, and explain what would change the plan. Prompt contact is especially important when a report remains preliminary or different clinicians hold incomplete pieces of the evaluation.
Urgency should be guided by the severity and duration of the symptom. A rapidly changing breast mass, severe skin change, or new bloody discharge warrants prompt medical assessment rather than waiting for routine surveillance.
Bottom Line
A BI-RADS score organizes an imaging finding, a level of concern, and a recommended pathway; it is not a diagnosis hidden in one number. You need the finding, its location, the reason for the assessment, and the named follow-up to understand the result fully.
Categories 1 and 2 are reassuring, category 3 may require short-interval surveillance, and categories 4 and 5 call for progressively more intensive evaluation. Category 6 follows biopsy-confirmed cancer, while category 0 means the examination still needs completion.
Use the complete report to identify the final assessment and contact the clinician coordinating your care. Promptly report new symptoms or an unarranged recommendation, because the safest next step depends on both the imaging result and your clinical situation.
FAQ
What do the BI-RADS scores mean?
A 0-through-6 rating system summarizes breast-imaging findings and indicates the appropriate evaluation pathway. They reflect the radiologist’s concern after reviewing mammography, breast ultrasound, or breast MRI, but they do not serve as a cancer diagnosis by themselves.
What does each BI-RADS category from 0 to 6 indicate?
Category 0 is incomplete, 1 is negative, 2 is benign, 3 is probably benign, 4 is suspicious, 5 is highly suspicious, and 6 indicates biopsy-confirmed cancer. Each category links an imaging assessment to a different evaluation pathway.
What is the difference between BI-RADS 1, 2, 3, 4, 5, and 6?
Categories 1 and 2 indicate negative or benign findings. Category 3 carries no greater than 2% estimated malignancy risk, categories 4 and 5 indicate progressively higher concern, and category 6 means cancer has already been confirmed through biopsy.
Does a BI-RADS 3 result mean a person has breast cancer?
No. Category 3 describes a probably benign finding with an estimated malignancy risk of no greater than 2%. Short-interval follow-up is central for many cases, with the specific plan determined by the finding, imaging method, and clinical context.
What follow-up is recommended for each BI-RADS category?
Category 0 requires additional imaging; categories 1 and 2 may fit routine screening. Category 3 often uses short-interval imaging, categories 4 and 5 may require additional examination or biopsy, and category 6 leads into specialist planning based on the confirmed cancer.
What is the difference between BI-RADS 4 and BI-RADS 5?
Category 4 covers an estimated malignancy risk above 2% and below 95% and may be divided into 4A, 4B, or 4C. Category 5 carries an estimated risk of at least 95% and normally leads to tissue sampling.
